{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:31:36Z","timestamp":1788352296597,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.neo.2025.101197","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T04:02:58Z","timestamp":1750219378000},"page":"101197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Prognostic role of high MTAP expression is reversed by the ERG status in prostate cancer treated by radical prostatectomy"],"prefix":"10.1016","volume":"67","author":[{"given":"Natalia","family":"Gorbokon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9106-6595","authenticated-orcid":false,"given":"Seyma","family":"B\u00fcy\u00fccek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Plage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neele","family":"Heckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0158-4258","authenticated-orcid":false,"given":"Ronald","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Lennartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Kluth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Teljuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7542-4340","authenticated-orcid":false,"given":"Claudia","family":"Hube-Magg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Minner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eike","family":"Burandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4257-856X","authenticated-orcid":false,"given":"Till S.","family":"Clauditz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldemar","family":"Wilczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7884-4313","authenticated-orcid":false,"given":"David","family":"Dum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Hinsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Heinzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Haese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Schlomm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas M","family":"Luebke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Graefen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Steurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Bernreuther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4632-5372","authenticated-orcid":false,"given":"Luca","family":"Roma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5970-1803","authenticated-orcid":false,"given":"Lukas","family":"Bubendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Weinberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.neo.2025.101197_bib0001","doi-asserted-by":"crossref","first-page":"12324","DOI":"10.1016\/S0021-9258(18)67242-4","article-title":"Purification and characterization of 5\u2032-deoxy-5\u2032-methylthioadenosine phosphorylase from human placenta","volume":"261","author":"Della Ragione","year":"1986","journal-title":"J. Biol. Chem."},{"issue":"7283","key":"10.1016\/j.neo.2025.101197_bib0002","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nature08822","article-title":"The landscape of somatic copy-number alteration across human cancers","volume":"463","author":"Beroukhim","year":"2010","journal-title":"Nature"},{"issue":"7793","key":"10.1016\/j.neo.2025.101197_bib0003","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","article-title":"Pan-cancer analysis of whole genomes","volume":"578","author":"Consortium","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.neo.2025.101197_bib0004","article-title":"Ensembl 2024","author":"Harrison","year":"2023","journal-title":"Nucleic. Acids. Res."},{"issue":"1","key":"10.1016\/j.neo.2025.101197_bib0005","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1038\/s41467-022-29397-z","article-title":"MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers","volume":"13","author":"Alhalabi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2025.101197_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1264785","article-title":"The potential and challenges of targeting MTAP-negative cancers beyond synthetic lethality","volume":"13","author":"Bray","year":"2023","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.neo.2025.101197_bib0007","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.molcel.2016.11.003","article-title":"Arginine Methylation: The Coming of Age","volume":"65","author":"Blanc","year":"2017","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.neo.2025.101197_bib0008","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1152\/physrev.00047.2011","article-title":"S-adenosylmethionine in liver health, injury, and cancer","volume":"92","author":"Lu","year":"2012","journal-title":"Physiol. Rev."},{"issue":"8","key":"10.1016\/j.neo.2025.101197_bib0009","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1073\/pnas.1510959113","article-title":"Crystallography captures catalytic steps in human methionine adenosyltransferase enzymes","volume":"113","author":"Murray","year":"2016","journal-title":"Proc. Natl. Acad. Sci. u S. a"},{"issue":"6278","key":"10.1016\/j.neo.2025.101197_bib0010","first-page":"1214","article-title":"MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells","volume":"351","author":"Kryukov","year":"2016","journal-title":"Science (1979)"},{"issue":"11","key":"10.1016\/j.neo.2025.101197_bib0011","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1158\/2159-8290.CD-23-0669","article-title":"MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Models and Patients with MTAP-Deleted Cancer","volume":"13","author":"Engstrom","year":"2023","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.neo.2025.101197_bib0012","doi-asserted-by":"crossref","first-page":"58","DOI":"10.36401\/JIPO-22-1","article-title":"Protein Arginine Methyltransferase 5 (PRMT5) Inhibitors in Oncology Clinical Trials: a review","volume":"5","author":"Feustel","year":"2022","journal-title":"J. ImmunOther Precis. Oncol."},{"issue":"12","key":"10.1016\/j.neo.2025.101197_bib0013","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1093\/carcin\/17.12.2603","article-title":"Absence of p16\/MTS1 gene mutations in human prostate cancer","volume":"17","author":"Chen","year":"1996","journal-title":"Carcinogenesis"},{"issue":"3-4","key":"10.1016\/j.neo.2025.101197_bib0014","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1023\/A:1015575125780","article-title":"Chromosomal deletions and tumor suppressor genes in prostate cancer","volume":"20","author":"Dong","year":"2001","journal-title":"Cancer Metastasis Rev."},{"issue":"12","key":"10.1016\/j.neo.2025.101197_bib0015","doi-asserted-by":"crossref","first-page":"14380","DOI":"10.18632\/oncotarget.7486","article-title":"The essential role of methylthioadenosine phosphorylase in prostate cancer","volume":"7","author":"Bistulfi","year":"2016","journal-title":"Oncotarget."},{"issue":"2","key":"10.1016\/j.neo.2025.101197_bib0016","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.5301\/jbm.5000242","article-title":"Correlation between chromosome 9p21 locus deletion and prognosis in clinically localized prostate cancer","volume":"32","author":"Barros","year":"2017","journal-title":"Int. J. Biol. Markers"},{"issue":"23","key":"10.1016\/j.neo.2025.101197_bib0017","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1158\/0008-5472.CAN-23-0816","article-title":"Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal","volume":"83","author":"de Bruijn","year":"2023","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.neo.2025.101197_bib0018","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/bjc.1996.325","article-title":"p16 mutations\/deletions are not frequent events in prostate cancer","volume":"74","author":"Tamimi","year":"1996","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.neo.2025.101197_bib0019","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/ng1095-210","article-title":"Frequency of homozygous deletion at p16\/CDKN2 in primary human tumours","volume":"11","author":"Cairns","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neo.2025.101197_bib0020","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000002297","article-title":"Prevalence of MTAP deficiency in human cancer: a tissue microarray study on 17,078 tumors from 149 different tumor types","author":"Gorbokon","year":"2024","journal-title":"Am. J. Surg. Pathol."},{"issue":"11","key":"10.1016\/j.neo.2025.101197_bib0021","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/modpathol.2008.104","article-title":"Clinical significance of p53 alterations in surgically treated prostate cancers","volume":"21","author":"Schlomm","year":"2008","journal-title":"Mod. Pathol."},{"issue":"4","key":"10.1016\/j.neo.2025.101197_bib0022","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.eururo.2015.10.029","article-title":"Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens","volume":"69","author":"Sauter","year":"2016","journal-title":"Eur. Urol."},{"issue":"7","key":"10.1016\/j.neo.2025.101197_bib0023","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nm0798-844","article-title":"Tissue microarrays for high-throughput molecular profiling of tumor specimens","volume":"4","author":"Kononen","year":"1998","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.neo.2025.101197_bib0024","first-page":"261","article-title":"The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkers","volume":"40","author":"Tennstedt","year":"2012","journal-title":"Int. J. Oncol."},{"issue":"2","key":"10.1016\/j.neo.2025.101197_bib0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ccr.2013.01.002","article-title":"Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer","volume":"23","author":"Weischenfeldt","year":"2013","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.neo.2025.101197_bib0026","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/pros.21241","article-title":"High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer","volume":"71","author":"Minner","year":"2011","journal-title":"Prostate"},{"issue":"9","key":"10.1016\/j.neo.2025.101197_bib0027","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1158\/0008-5472.CAN-12-1342","article-title":"CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer","volume":"73","author":"Burkhardt","year":"2013","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.neo.2025.101197_bib0028","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/modpathol.2012.236","article-title":"Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions","volume":"26","author":"Kluth","year":"2013","journal-title":"Mod. Pathol."},{"issue":"2","key":"10.1016\/j.neo.2025.101197_bib0029","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ajpath.2012.04.026","article-title":"Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancer","volume":"181","author":"Krohn","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.neo.2025.101197_bib0030","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/path.4223","article-title":"Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers","volume":"231","author":"Krohn","year":"2013","journal-title":"J. Pathol."},{"issue":"10","key":"10.1016\/j.neo.2025.101197_bib0031","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/gcc.22645","article-title":"13q deletion is linked to an adverse phenotype and poor prognosis in prostate cancer","volume":"57","author":"Kluth","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"issue":"52","key":"10.1016\/j.neo.2025.101197_bib0032","doi-asserted-by":"crossref","first-page":"86339","DOI":"10.18632\/oncotarget.13404","article-title":"Deletion of 18q is a strong and independent prognostic feature in prostate cancer","volume":"7","author":"Kluth","year":"2016","journal-title":"Oncotarget."},{"issue":"1","key":"10.1016\/j.neo.2025.101197_bib0033","doi-asserted-by":"crossref","first-page":"379","DOI":"10.18632\/oncotarget.13425","article-title":"Deletion of 8p is an independent prognostic parameter in prostate cancer","volume":"8","author":"Kluth","year":"2017","journal-title":"Oncotarget."},{"issue":"29","key":"10.1016\/j.neo.2025.101197_bib0034","doi-asserted-by":"crossref","first-page":"27966","DOI":"10.18632\/oncotarget.4626","article-title":"Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer","volume":"6","author":"Kluth","year":"2015","journal-title":"Oncotarget."},{"issue":"65","key":"10.1016\/j.neo.2025.101197_bib0035","doi-asserted-by":"crossref","first-page":"108923","DOI":"10.18632\/oncotarget.22408","article-title":"Deletion lengthening at chromosomes 6q and 16q targets multiple tumor suppressor genes and is associated with an increasingly poor prognosis in prostate cancer","volume":"8","author":"Kluth","year":"2017","journal-title":"Oncotarget."},{"issue":"6","key":"10.1016\/j.neo.2025.101197_bib0036","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/ijc.28784","article-title":"Clinical significance of different types of p53 gene alteration in surgically treated prostate cancer","volume":"135","author":"Kluth","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.neo.2025.101197_bib0037","doi-asserted-by":"crossref","DOI":"10.1002\/2056-4538.70012","article-title":"Loss of MTAP expression is strongly linked to homozygous 9p21 deletion, unfavorable tumor phenotype, and noninflamed microenvironment in urothelial bladder cancer","volume":"11","author":"Gorbokon","year":"2025","journal-title":"J. Pathol. Clin. Res."},{"issue":"10","key":"10.1016\/j.neo.2025.101197_bib0038","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nmeth.3995","article-title":"A proposal for validation of antibodies","volume":"13","author":"Uhlen","year":"2016","journal-title":"Nat. Methods"},{"issue":"2","key":"10.1016\/j.neo.2025.101197_bib0039","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0304-4165(80)90320-7","article-title":"The stimulatory effect of testosterone propionate and 17 beta-estradiol on 5\u2032-methylthioadenosine phosphorylase activity in rat target tissues","volume":"627","author":"Nicolette","year":"1980","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.neo.2025.101197_bib0040","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0006-291X(80)80116-1","article-title":"Androgenic regulation of 5\u2032-deoxy-5\u2032-methylthioadenosine concentrations and methylthioadenosine phosphorylase activity in relation to polyamine metabolism of rat prostate","volume":"95","author":"Seidenfeld","year":"1980","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.neo.2025.101197_bib0041","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.eururo.2014.06.027","article-title":"TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancer","volume":"66","author":"Steurer","year":"2014","journal-title":"Eur. Urol."},{"issue":"18","key":"10.1016\/j.neo.2025.101197_bib0042","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.1158\/1078-0432.CCR-11-1251","article-title":"ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy","volume":"17","author":"Minner","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2025.101197_bib0043","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1186\/1471-2407-11-507","article-title":"TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-beta signaling","volume":"11","author":"Brase","year":"2011","journal-title":"BMC. Cancer"},{"issue":"2","key":"10.1016\/j.neo.2025.101197_bib0044","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ijc.32957","article-title":"Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancers","volume":"147","author":"Luebke","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.neo.2025.101197_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128525","article-title":"Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers","volume":"10","author":"Burdelski","year":"2015","journal-title":"PLoS. One"},{"issue":"6","key":"10.1016\/j.neo.2025.101197_bib0046","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/ijc.27768","article-title":"Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression in ERG-fusion-positive cancers","volume":"132","author":"Muller","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.neo.2025.101197_bib0047","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/pros.23736","article-title":"Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers","volume":"79","author":"Minner","year":"2019","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.neo.2025.101197_bib0048","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1007\/s12253-020-00861-9","article-title":"Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG Fusions","volume":"26","author":"Bernreuther","year":"2020","journal-title":"Pathol. Oncol. Res."},{"issue":"7","key":"10.1016\/j.neo.2025.101197_bib0049","doi-asserted-by":"crossref","DOI":"10.1177\/1010428318824815","article-title":"The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer","volume":"41","author":"Buscheck","year":"2019","journal-title":"Tumour. Biol."},{"issue":"5","key":"10.1016\/j.neo.2025.101197_bib0050","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00428-020-02834-4","article-title":"Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancers","volume":"477","author":"Moller","year":"2020","journal-title":"Virchows Arch."},{"issue":"6","key":"10.1016\/j.neo.2025.101197_bib0051","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/ijc.28778","article-title":"The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG-negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression","volume":"135","author":"Grupp","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"7","key":"10.1016\/j.neo.2025.101197_bib0052","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/jclinpath-2012-201335","article-title":"Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers","volume":"66","author":"Stumm","year":"2013","journal-title":"J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.neo.2025.101197_bib0053","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1476-4598-12-145","article-title":"High mitochondria content is associated with prostate cancer disease progression","volume":"12","author":"Grupp","year":"2013","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.neo.2025.101197_bib0054","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12885-017-3956-3","article-title":"High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer","volume":"18","author":"Heumann","year":"2018","journal-title":"BMC. Cancer"},{"issue":"9","key":"10.1016\/j.neo.2025.101197_bib0055","doi-asserted-by":"crossref","first-page":"12655","DOI":"10.1007\/s13277-016-5167-y","article-title":"p16 upregulation is linked to poor prognosis in ERG negative prostate cancer","volume":"37","author":"Burdelski","year":"2016","journal-title":"Tumour. Biol."},{"issue":"1","key":"10.1016\/j.neo.2025.101197_bib0056","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1038\/s41598-017-02279-x","article-title":"Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer","volume":"7","author":"Heumann","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.neo.2025.101197_bib0057","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/carcin\/bgw116","article-title":"Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer","volume":"38","author":"Wilczak","year":"2017","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.neo.2025.101197_bib0058","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020286","article-title":"High-Level gamma-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer","volume":"18","author":"Melling","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neo.2025.101197_bib0059","first-page":"5","article-title":"ERG signaling in prostate cancer is driven through PRMT5-dependent methylation of the Androgen Receptor","author":"Mounir","year":"2016","journal-title":"Elife"},{"issue":"10013","key":"10.1016\/j.neo.2025.101197_bib0060","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0140-6736(14)61947-4","article-title":"Prostate cancer","volume":"387","author":"Attard","year":"2016","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.neo.2025.101197_bib0061","doi-asserted-by":"crossref","DOI":"10.3390\/genes14050956","article-title":"Prognostic Values of Gene Copy Number Alterations in Prostate Cancer","volume":"14","author":"Alfahed","year":"2023","journal-title":"Genes. (Basel)"},{"issue":"2","key":"10.1016\/j.neo.2025.101197_bib0062","first-page":"105","article-title":"Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way","volume":"1654","author":"Santarosa","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.neo.2025.101197_bib0063","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1074\/mcp.M115.055772","article-title":"Methylthioadenosine (MTA) Regulates Liver Cells Proteome and Methylproteome: Implications in Liver Biology and Disease","volume":"15","author":"Bigaud","year":"2016","journal-title":"Mol. Cell Proteomics."}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625000776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625000776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T07:07:43Z","timestamp":1753686463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558625000776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":63,"alternative-id":["S1476558625000776"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2025.101197","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic role of high MTAP expression is reversed by the ERG status in prostate cancer treated by radical prostatectomy","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2025.101197","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101197"}}